Cardiac resynchronization therapy: A regulatory perspective - 17/08/11
Doi : 10.1016/j.ahj.2005.05.023
Warren K. Laskey, MD a, ⁎ 
, William H. Maisel, MD, MPH b
, William H. Maisel, MD, MPH b a Division of Cardiology, Department of Medicine, University of New Mexico School of Medicine, Albuquerque, NM
b Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
⁎Reprint requests: Warren K. Laskey, MD, Division of Cardiology, Department of Medicine, MSC10-5550, 1 University of New Mexico, Albuquerque, NM 87131-0001.
Il testo completo di questo articolo è disponibile in PDF.
Mappa
| Dr. Laskey is the immediate past chairperson and Dr. Maisel is the current chairperson of the Food and Drug Administration Circulatory System Medical Devices Advisory Panel. The opinions expressed in the article are those of the authors and not necessarily those of the Food and Drug Administration. |
© 2006
Mosby, Inc. Tutti i diritti riservati.
Vol 151 - N° 4
P. 757-761 - aprile 2006 Ritorno al numero
Articolo precedente
- Information for Authors
- From efficacy to safety concerns: A STEP forward or a step back for clinical research and intercessory prayer? : The Study of Therapeutic Effects of Intercessory Prayer (STEP)
- Mitchell W. Krucoff, Suzanne W. Crater, Kerry L. Lee
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?